The View From Both Sides- Pharma and CRO Insights- An Interview with Eef Verhaegen
Pharma IQ: What are the major challenges currently being faced in clinical trials supply?
Eef Verhaegen: I think currently that the major challenges are definitely linked to ancillary supplies, especially with the Sunshine Act coming into place, into the US, as well as the new GDP guidelines that are being brought into place at the start of last year. There’s more aim for a central supply, which is in a lot o...
To continue reading this story
Please note: That all fields marked with an asterisk (*) are required.